Intec Pharma is a clinical-stage biopharmaceutical company that is using proprietary Accordion Pill platform technology to develop drugs aimed at improving the efficacy and safety of existing drugs and those under development. The Accordion Pill is an oral drug delivery system that utilizes an efficient gastric retention and specific release mechanism. Its pipeline includes two clinical-stage product candidates: AP-CD/LD for the treatment of Parkinson's disease symptoms in advanced patients and AP-cannabinoids for pain indications. The company also has a feasibility agreement with Novartis Pharmaceuticals for the development of a custom-designed Accordion Pill for a proprietary compound.